|
C6ORF134 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.316600E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.340200E-03 |
| Normal-vs-Stage2 |
1.546770E-01 |
| Normal-vs-Stage3 |
1.497970E-01 |
| Normal-vs-Stage4 |
1.632220E-02 |
| Stage1-vs-Stage2 |
8.447600E-01 |
| Stage1-vs-Stage3 |
4.374600E-01 |
| Stage1-vs-Stage4 |
5.625600E-01 |
| Stage2-vs-Stage3 |
7.167800E-01 |
| Stage2-vs-Stage4 |
5.494400E-01 |
| Stage3-vs-Stage4 |
2.479600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.778000E-02 |
| Normal-vs-AfricanAmerican |
8.413800E-04 |
| Normal-vs-Asian |
5.259700E-02 |
| Caucasian-vs-AfricanAmerican |
7.339900E-03 |
| Caucasian-vs-Asian |
1.471640E-02 |
| AfricanAmerican-vs-Asian |
5.718400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.304600E-01 |
| Normal-vs-Female |
1.55511999999636E-05 |
| Male-vs-Female |
1.030060E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.902600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.645100E-04 |
| Normal-vs-Age(61-80Yrs) |
8.475700E-02 |
| Normal-vs-Age(81-100Yrs) |
9.402600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.540800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.963000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.623400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.548300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.725240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.998200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.359900E-04 |
| Normal-vs-Grade 2 |
3.082300E-03 |
| Normal-vs-Grade 3 |
9.489600E-02 |
| Normal-vs-Grade 4 |
2.820000E-01 |
| Grade 1-vs-Grade 2 |
2.697000E-03 |
| Grade 1-vs-Grade 3 |
1.120710E-03 |
| Grade 1-vs-Grade 4 |
5.000500E-04 |
| Grade 2-vs-Grade 3 |
2.363800E-01 |
| Grade 2-vs-Grade 4 |
2.654000E-01 |
| Grade 3-vs-Grade 4 |
8.312000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.982010E-02 |
| Normal-vs-ccB subtype |
2.096600E-01 |
| ccA subtype-vs-ccB subtype |
4.706000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.561100E-03 |
| Normal-vs-N1 |
1.708810E-01 |
| N0-vs-N1 |
9.126400E-01 |
|
|
